What to monitor Track the following metrics to assess whether the levocarnitine addition is providing value: Body composition changes (use DEXA, InBody, or similar if accessible) Energy levels and exercise performance GI symptoms (compare to baseline on tirzepatide alone if possible) Liver function markers (ALT, AST) if baseline values were elevated General well-being and recovery quality If after 8 to 12 weeks the levocarnitine addition has not produced noticeable improvements in energy, exercise performance, or body composition compared to tirzepatide alone, consider adjusting your protocol or switching to a different compound blend
Run together, the two give a more complete view of both what you've been exposed to and the metabolic context around it
IGF-1 LR3 (Insulin-like Growth Factor-1 Long Arg3) is a synthetic analog of naturally occurring IGF-1, a hormone your body produces primarily in the liver in response to growth hormone signaling
(7) Contraindications and side effects: Pyridostigmine is contraindicated in mechanical intestinal or urinary obstruction
Early change in bilirubin levels is an important prognostic factor in severe alcoholic hepatitis treated with prednisolone
1000